top of page

AI for
Cell Therapy

building best-in-class cell therapies through automation & computation

The new generation of
Chimeric Antigen Receptors

At, we use an AI-first approach to design new CARs, combined with our high-throughput screening platform to discover best-in-class CARs to power the cell therapy revolution.


Our ultimate goal is to provide curative therapeutics to as many patients as possible.

Discover Faster

Our streamlined development approach allows for comprehensive discovery of novel CARs in three months time.

AI powered

Machine Learning  accelerates our discovery process by selecting best-in-class lead candidates for your target.

Build & Test

Our automated high-throughput wet-lab platform tests and optimises every domain of the CAR systematically and can assess thousands of CARs for functionality to identify best-in-class performers.


We are continuously looking for partners who would like to bring their CAR-based therapeutics to the next level.  Our aim is to provide our partners with the best receptors to ensure successful clinical outcome.

Are You Ready to empower
your CAR discovery?

Do you want to develop best-in-class CARs faster?


Want to join the team?


bottom of page